| |
Home »
News » 01/06 »
Eli Lilly forms 5 year Indian partnership
Eli Lilly forms 5 year Indian partnership
Date published: 05/01/2006
Eli Lilly
has signed a five-year collaboration contract with the India firm Jubilant
Organosys. The agreement, put into place with the Jubilant subsidiaries
Jubilant Biosys and Jubilant Chemsys, will focus on the development of new
drugs in a range of areas.
Jubilant Biosys and Jubilant Chemsys will
work on initial stages of drug discovery, sharing its developments, and
analysis to bring drugs to fruition. The financial details of the contract have
not been disclosed but Eli Lilly will pay Jubilant on the meeting of certain
development milestones.
Jubilant, which has chemical as well as
pharmaceutical divisions, employs around 2,500 people in India and abroad and
had a revenue in 2005 of around $270 million.
© Adfero Ltd
Disclaimer
AllAboutMedicalSales excludes any warranty, express or implied, as to
the quality, accuracy, timeliness, completeness or fitness for a particular
purpose of this briefing. AllAboutMedicalSales will not be liable for any
claims, penalties, losses, damages, costs, or expenses arising from the use of
or inability to use this briefing or from any unauthorised access to or
alteration of the Briefing. AllAboutMedicalSales makes no warranty that the
contents of this briefing are compatible with all computer systems and
browsers.
|
